Company Profile

I.Ceram specializes in the design, manufacture and marketing of orthopedic implants (metal, polymer and ceramic implants in porous alumina). The group provides prostheses for shoulder, spine, hip, tibia, ankle and foot as well as for osteosynthetic applications. Net sales by source of income break down between sales of non-ceramic products (92.2%) and sales of ceramic products (7.8%). France accounts for 72.2% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

01/24/01	I.CERAM SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
06/24/06	I.CERAM SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
07/24/07	I.Ceram: successful animal health implant
17/24/17	I.Ceraam: up to 1.4 million in new financing
21/23/21	I.CERAM SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/23/27	An unknown buyer signed an agreement to acquire 49% stake in ADDIDREAM.	CI
28/22/28	I.CERAM SA Reports Earnings Results for the Full Year Ended December 31, 2021	CI
30/21/30	I.CERAM SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
01/21/01	I.CERAM SA Reports Earnings Results for the Full Year Ended December 31, 2020	CI
30/20/30	I.CERAM SA Auditor Raises 'Going Concern' Doubt	CI
30/19/30	I.CERAM SA acquired an unknown minority stake in Dussartre SAS.	CI
13/18/13	I.CERAM SA announced that it has received €3.46749 million in funding	CI
12/18/12	I.CERAM SA announced that it expects to receive €4 million in funding	CI

06/24/06	I CERAM : Comptes définitifs de l’exercice 2023 & Mise à disposition du Document d’Enregistrement Universel	PU
25/24/25	I CERAM : Prorogation au 30 septembre 2024 du délai de tenue de l’Assemblée Générale statuant sur les comptes de l’exercice clos au 31 décembre 2023	PU
07/24/07	I CERAM : Résultats annuels 2023	PU
30/24/30	I CERAM : Report de publication des résultats annuels 2023 et du Document d’Enregistrement Universel 2023	PU
24/24/24	I Ceram : annonce l’ouverture d’une procédure collective afin de sécuriser son avenir	PU

27/24/27	I CERAM : Liquidation Judiciaire avec poursuite d'activité jusqu'au 06 décembre Suspension du cours de Bourse
07/24/07	I Ceram : Le Professeur Pascal Leprince, Chef du service de chirurgie cardiaque de l’hôpital de la Pitié-Salpêtrière à Paris, donne son accord pour la mise en place d’une étude clinique pilote
04/24/04	I Ceram : Résultats du 1er semestre 2024
01/24/01	I CERAM : Résultat du 1er semestre 2024
12/24/12	I Ceram : Assemblée générale mixte du 26 septembre 2024 – Mise à disposition des documents préparatoires

Manager	Title	Age	Since
André Kérisit CEO	Chief Executive Officer	62	15/05/2013
Eric Denes CTO	Chief Tech/Sci/R&D Officer	-	01/09/2016

Director	Title	Age	Since
André Kérisit CHM	Chairman	62	15/05/2013
Alain Vassal BRD	Director/Board Member	75	18/09/2014
Guy Viel BRD	Director/Board Member	85	15/05/2013

I.Ceram Share Price

Stocks

ALICR

FR0014005IU4

Medical Equipment, Supplies & Distribution

Latest news: I.Ceram

Press Releases: I.Ceram

News in other languages: I.Ceram

Managers and Directors: I.Ceram

Medical Devices & Implants

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
I.CERAM	-.--%	-.--%	-	-	2L
ABBOTT LABORATORIES	-0.69%	+6.11%	-11.66%	+14.15%	19TCr
MEDTRONIC PLC	-0.41%	+5.25%	+9.62%	+36.27%	12TCr
STRYKER CORPORATION	+1.22%	+3.03%	-13.29%	+12.43%	12TCr
ESSILORLUXOTTICA	-0.38%	+3.26%	-42.00%	+6.28%	9.48TCr
CENCORA, INC.	+0.79%	+4.65%	-0.13%	+74.46%	6.5TCr
BECTON, DICKINSON AND COMPANY	-0.22%	+1.61%	+11.77%	-23.46%	5.4TCr
IDEXX LABORATORIES, INC.	+0.06%	+19.74%	-7.04%	+56.54%	5.29TCr
HOYA CORPORATION	-1.45%	-7.57%	-2.88%	+55.56%	5.23TCr
ALCON INC.	+0.23%	+3.85%	-1.42%	-10.23%	3.52TCr
Average	+0.06%	+4.25%	-6.34%	+24.67%	8.7TCr
Weighted average by Cap.	+0.23%	+4.39%	-8.36%	+23.31%